Episode 174: ASCO 2022: Cell free DNA as a biomarker in bladder cancer
The Uromigos - Podcast készítő The Uromigos
Amir Goldkorn describes translational findings from a phase 2 bladder trial.
The Uromigos - Podcast készítő The Uromigos
Amir Goldkorn describes translational findings from a phase 2 bladder trial.
